Beam Therapeutics, Inc. (BEAM)
26.92
+0.93
(+3.58%)
USD |
NASDAQ |
Feb 12, 16:00
26.99
+0.07
(+0.26%)
After-Hours: 18:48
Beam Therapeutics Shareholders Equity (Quarterly) : 966.00M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Intellia Therapeutics, Inc. | 748.42M |
| Pacific Biosciences of California, Inc. | 36.09M |
| Regeneron Pharmaceuticals, Inc. | 31.26B |
| Twist Bioscience Corp. | 456.10M |
| Ionis Pharmaceuticals, Inc. | 617.97M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.311B |
| Total Liabilities (Quarterly) | 345.08M |
| Debt to Equity Ratio | 0.1567 |
| Current Ratio | 6.018 |
| Net Debt Paydown Yield | 0.11% |